From: biospace.com Xcision Medical Systems, LLC announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest option in noninvasive breast cancer treatment. “We are excited to bring GammaPod to the European market, where the need for more efficient, precise breast cancer radiotherapy treatments is increasing,” said Cedric …